MYLLE PHARMA
MYLLE PHARMA has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €479k and a net result of €128k. The computed 12-month bankruptcy probability is 0.8% (low).
| Equity | €479k |
| Net result | €128k |
| Active | 11 yrs |
| Board | 1 |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Fiscal year | 2025 |
|---|---|
| Deposit | abbreviated schema |
| Revenue | - |
| EBITDA | €66k |
| Net profit | €128k |
| Cash flow | €131k |
| Staff costs | - |
| Income taxes | €24k |
| Dividends | €240k |
| Total assets | €948k |
| Equity | €479k |
| Debt | €469k |
| of which ≤ 1y | €246k |
| of which > 1y | €223k |
| Working capital | €-167k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.32 |
| Quick ratio | 0.32 |
| Working capital ratio | -17.6% |
| Solvency | 50.5% |
| Debt / equity | 0.98 |
| Long-term debt ratio | 0.47 |
| Interest coverage | 5.88 |
| Gross margin | - |
| Net margin | - |
| ROA | 13.5% |
| ROE | 26.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €948k |
| Fixed assets | 21/28 | €868k |
| Tangible fixed assets | 22/27 | €8k |
| Financial fixed assets | 28 | €860k |
| Current assets | 29/58 | €79k |
| Cash & bank | 54/58 | €78k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €948k |
| Equity | 10/15 | €479k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €460k |
| Amounts payable | 17/49 | €469k |
| Amounts payable after one year | 17 | €223k |
| Amounts payable within one year | 42/48 | €246k |
| Trade debts payable within one year | 44 | €3k |
| Income statement | ||
| Gross operating margin | 9900 | €68k |
| Operating result | 9901 | €63k |
| Financial income | 75 | €100k |
| Financial charges | 65 | €11k |
| Result before taxes | 9903 | €152k |
| Income taxes | 67/77 | €24k |
| Net result for the period | 9904 | €128k |
| Result to be appropriated | 9905 | €128k |
-
MYLLE HeleenDirectorState Gazette act 22320521 (29-03-2022)Current29-03-2022 → present
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 29-10-2014 |
| Status | Active |
| Postal code | 8570 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34018C0459/00R002 | Flanders | 1,344 m² | 1 · 113 m² | 11.2 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
29-03-2022 MYLLE Heleen appointed as director
- MYLLE Heleen, Bestuurder
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "MYLLE Heleen",
"address": "Anzegem, Stijn Streuvelsstraat 26",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "MYLLE Heleen",
"address": "Anzegem, Stijn Streuvelsstraat 26",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "niet_statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Katrien DEVAERE",
"firm_city": null,
"firm_name": "BOES \u0026 DEVAERE, GEASSOCIEERDE NOTARISSEN",
"office_city": "Kortrijk",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-03-29",
"filing_date": "2022-03-25",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-03-24",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0566.940.155",
"name_full": "MYLLE PHARMA",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Katrien DEVAERE",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"afschrift van de akte aanpassing statuten aan het wetboek van vennootschappen en verenigingen \u2013 vaststelling rechtsvorm als besloten vennootschap (BV) \u2013 vaststelling dat het kapitaal en de wettelijke reserves van rechtswege omgevormd worden in een statutair onbeschikbare eigen vermogensrekening \u2013 beschikbaarstelling van de eigen vermogensrekening \u2013 wijziging voorwerp - be\u00EBindiging mandaat zaakvoerder \u2013 aanstelling niet-statutaire bestuurder \u2013 vaststelling statuten",
"geco\u00F6rdineerde statuten"
],
"corrected_publication_numac": null
}| Legal nameNL | MYLLE PHARMA |